| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Identiv (NASDAQ:INVE) sees Q4 sales of $5.400 million-$5.900 million vs $5.267 million analyst estimate.
Identiv (NASDAQ:INVE) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.22) by 31...
B. Riley Securities analyst Craig Ellis maintains Identiv (NASDAQ:INVE) with a Buy and lowers the price target from $6.5 to $6.
Identiv (NASDAQ:INVE) sees Q3 sales of $4.800 million-$5.200 million vs $5.767 million analyst estimate.
Identiv (NASDAQ:INVE) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.25) by ...